Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 58, Number 4, February 26, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaaja, E.
Right arrow Articles by Hiilesmaa, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaaja, E.
Right arrow Articles by Hiilesmaa, V.
Related Collections
Right arrow All Medical/Systemic disease
Right arrow Prevalence studies
Right arrow Antiepileptic drugs
Neurology 2002;58:549-553
© 2002 American Academy of Neurology

Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate

Erja Kaaja, MSc(Pharm);, Risto Kaaja, MD, PhD;, Riitta Matila, MD; and Vilho Hiilesmaa, MD, PhD

From the Department of Obstetrics and Gynecology (Drs. R. Kaaja, Matila, and Hiilesmaa, and E. Kaaja), Helsinki University Central Hospital, and Division of Pharmacology and Toxicology (E. Kaaja), Department of Pharmacy, University of Helsinki, Finland.

Address correspondence and reprint requests to Dr. V. Hiilesmaa, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Box 140, 00029 HYKS, Finland; e-mail: ville.hiilesmaa{at}hus.fi

Background: Case reports suggest that maternal hepatic enzyme-inducing antiepileptic drugs (AED) increase the risk for neonatal bleeding. Antenatal administration of vitamin K1 to mothers using these drugs therefore is widely recommended. There are, however, no studies on the incidence of this complication.

Objective: To assess the occurrence of bleeding complications in newborns exposed to maternal enzyme-inducing AED in utero.

Methods: The authors prospectively followed 662 pregnancies in women with epilepsy who used enzyme-inducing AED. Of the 667 neonates, 463 were exposed to carbamazepine, 212 to phenytoin, 44 to phenobarbital, 11 to primidone, and 7 to oxcarbazepine. The control subjects were 1,324 nonepileptic pregnancies (1,334 neonates) matched for maternal age, parity, number of fetuses, and delivery date. None of the mothers received vitamin K1 during pregnancy, but all infants received 1 mg vitamin K1 intramuscularly at birth.

Results: A bleeding complication was observed in five (0.7%) of the offspring exposed to maternal enzyme-inducing AED and in five (0.4%) control subjects (p = 0.3). After logistic regression analysis was performed, bleeding was associated with birth at <32 weeks of gestation (adjusted OR = 13; 95% CI = 2.7 to 64) and alcohol abuse (adjusted OR = 17; 95% CI = 1.8 to 162) but not with exposure to enzyme-inducing AED (adjusted OR = 1.1; 95% CI = 0.3 to 4.6; p = 0.8).

Conclusions: These data do not support the hypothesis that maternal enzyme-inducing AED increase the risk for bleeding in the offspring. Antenatal administration of vitamin K to these mothers may still be needed in selected cases.




This article has been cited by other articles:


Home page
NeurologyHome page
C. L. Harden, P. B. Pennell, B. S. Koppel, C. A. Hovinga, B. Gidal, K. J. Meador, J. Hopp, T. Y. Ting, W. A. Hauser, D. Thurman, et al.
Practice Parameter update: Management issues for women with epilepsy--Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society
Neurology, July 14, 2009; 73(2): 142 - 149.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M D O'Brien and S K Gilmour-White
Management of epilepsy in women
Postgrad. Med. J., May 1, 2005; 81(955): 278 - 285.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
E Hey
Vitamin K--what, why, and when
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F80 - F83.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
H. Yoshikawa, S. Yamazaki, T. Watanabe, and T. Abe
Vitamin K Deficiency in Severely Disabled Children
J Child Neurol, February 1, 2003; 18(2): 93 - 97.
[Abstract] [PDF]


Home page
JWatch PsychiatryHome page
Antiepileptic Drugs and Neonatal Bleeding
Journal Watch Psychiatry, August 21, 2002; 2002(821): 11 - 11.
[Full Text]


Home page
JWatch NeurologyHome page
Antiepileptic Drugs and Neonatal Bleeding
Journal Watch Neurology, June 27, 2002; 2002(627): 6 - 6.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.